Evidence map›Paper›PMID 41341293›Full record

ArticleFrontiers in cardiovascular medicine2025

Cardiac remodeling and exercise tolerance in small for gestational age: a follow-up cohort study from preadolescence into adolescence.

Rommy H Novoa, Dora Fabijanovic, Kilian Vellvé, Filip Loncaric, Mérida Rodríguez-López, Álvaro Sepúlveda-Martínez, Sebastian I Sarvari, Brenda Valenzuela-Alcaraz, Francesca Crovetto, Rosa Faner and 7 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rommy H Novoa *BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
Dora Fabijanovic *Centre for Biomedical Research on CardioVascular Diseases (CIBERCV), Institut Clínic Cardiovascular, Hospital Clínic, Barcelona, Spain.
Kilian Vellvé *BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
Filip LoncaricCentre for Biomedical Research on CardioVascular Diseases (CIBERCV), Institut Clínic Cardiovascular, Hospital Clínic, Barcelona, Spain.
Mérida Rodríguez-LópezBCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
Álvaro Sepúlveda-MartínezBCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
Sebastian I SarvariCentre for Biomedical Research on CardioVascular Diseases (CIBERCV), Institut Clínic Cardiovascular, Hospital Clínic, Barcelona, Spain.
Brenda Valenzuela-AlcarazBCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
Francesca CrovettoBCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
Rosa FanerUniversitat de Barcelona, Barcelona, Spain.
Alvar AgustíUniversitat de Barcelona, Barcelona, Spain.
Marta SitgesUniversitat de Barcelona, Barcelona, Spain.
Maja CikesDepartment of Cardiovascular Diseases, University of Zagreb School of Medicine, Zagreb, Croatia.
Gabriel BernardinoFRCB-Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Isabel Blanco *Universitat de Barcelona, Barcelona, Spain.
Bart Bijnens *BCN Medtech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain.
Fàtima Crispi *BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Being born small for gestational age (SGA) affects 7%-10% of newborns and is associated with increased cardiovascular risk and reduced exercise capacity in adulthood with unclear underlying mechanisms. Cardiac remodeling and dysfunction occur in fetuses and children born SGA, but it is uncertain whether and how these changes persist into adolescence. The aim of the study was to assess resting cardiovascular morphology and function together with exercise tolerance in adolescents born SGA. Methods: A perinatal cohort of 30 adolescents born SGA (defined as birth weight below the 10th centile) and 28 normal birth weight controls in a tertiary university hospital in Spain was included. Participants were followed from preadolescence (age 7-12 years) into adolescence (age 12-17 years) with echocardiography and incremental cardiopulmonary exercise test (CPET). Results: Although signs of cardiac remodeling and dysfunction were evident in SGA preadolescents, no significant differences in left ventricular dimensions and deformation could be demonstrated in SGA adolescents. During the follow-up period, the SGA cohort had a significantly higher increase in left ventricular (LV) base-to-apex length (SGA mean 17.61 ± 6.78 vs. controls 13.44 ± 5.12; Conclusion: Changes in cardiac shape and function, described in children born SGA, seem to be ameliorated in adolescence related to compensatory growth as compared to healthy controls. However, SGA adolescents had markedly reduced exercise tolerance.

Indexed as

adolescenceechocardiographyexercise tolerancefetal cardiovascular programmingsmall for gestational age

Identifiers

PMID41341293
PMCPMC12669170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.